ICH - Intracerebral HemorrhageICHNCT06654544
Epidemiology of Intracerebral Hemorrhage
An observational study of ICH - Intracerebral Hemorrhage, run by Assiut University.
Trial summary
Exploring the risk factors and associations of intracerebral hemorrhage Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- ICH - Intracerebral Hemorrhage
- How many people
- 60 participants
- Where
- No sites listed yet
- Study dates
- 30 Nov 2024to 31 Dec 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Stroke Patients
Who may be able to join
- both sex
- Age ≥ 18
- patients diagnosed with non traumatic hemorrhagic stroke on brain computed tomography scan
Who cannot join
- presence of space occupying lesion visible on brain computed tomography scan
- preceding brain trauma or post traumatic cerebral hemorrhagic stroke
- presence of ischemic stroke
- presence hemorrhagic transformation on top of acute ischemic stroke
Trial locations and contacts
No sites are listed yet.
Nageh Fouly, Professor contact
About this study
Official title: Prevalence and Clinical Features of Intracerebral Hemorrhage Among Stroke Patients Admitted to Assiut University Hospital
Exploring the risk factors and associations of intracerebral hemorrhage
Read the detailed description
Exploring the clinical characteristics and prevalence of intracerebral hemorrhage in Assiut University
- Conditions
- ICH - Intracerebral Hemorrhage
- Keywords
- prevalence, ich
- Medical subject headings
- Cerebral Hemorrhage, Hepatitis, Infectious Canine
What is being measured
The primary outcome is the main question the study is designed to answer.
Volume of Intracerebral Hemorrhage Among Stroke Patients Admitted to Assiut University Hospital
CT data (ABC/2) formula for intracerebral hemorrhage volume
Measured: At time of enrollment of study and after 24 hours
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Oct 2024
- Study start30 Nov 2024 (estimated)
- Primary completion29 Nov 2025 (estimated)
- Study completion31 Dec 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for ICH - Intracerebral HemorrhageStudies of the same condition, open and under way.
- More trials run by Assiut UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Assiut University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Norhan Mohamed Hassan Bakri, Assiut University
- Investigators
- Norhan MH Bakri, MD, Principal investigator, Assiut UniversityAhmed NasrEldein, Ass.Professor, Study director, Assiut University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06654544
- Sponsor's protocol ID
- 200913
- Acronym
- ICH
- Status last verified
- Oct 2024
- First submitted
- 14 Oct 2024
- Last updated
- 23 Oct 2024
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
An SJ, Kim TJ, Yoon BW. Epidemiology, Risk Factors, and Clinical Features of Intracerebral Hemorrhage: An Update. J Stroke. 2017 Jan;19(1):3-10. doi: 10.5853/jos.2016.00864. Epub 2017 Jan 31.
PubMed 28178408
Study at a glance
From the registry record, last updated by the sponsor on 23 Oct 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Prevalence and Clinical Features of Intracerebral Hemorrhage Among Stroke Patients Admitted to Assiut University Hospital
- ClinicalTrials.gov ID
- NCT06654544
- Acronym / sponsor ID
- ICH / 200913
- Conditions
- ICH - Intracerebral Hemorrhage
- Keywords
- prevalence, ich
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- Assiut UniversityUniversity, hospital or other
- Study start
- 30 Nov 2024 (estimated)
- Primary completion
- 29 Nov 2025 (estimated)
- Study completion
- 31 Dec 2025 (estimated)
- First posted
- 23 Oct 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Exploring the risk factors and associations of intracerebral hemorrhage
Detailed description
Exploring the clinical characteristics and prevalence of intracerebral hemorrhage in Assiut University
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Stroke Patients
Key inclusion criteria (3 listed)
- both sex
- Age ≥ 18
- patients diagnosed with non traumatic hemorrhagic stroke on brain computed tomography scan
Key exclusion criteria (4 listed)
- presence of space occupying lesion visible on brain computed tomography scan
- preceding brain trauma or post traumatic cerebral hemorrhagic stroke
- presence of ischemic stroke
- presence hemorrhagic transformation on top of acute ischemic stroke
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Volume of Intracerebral Hemorrhage Among Stroke Patients Admitted to Assiut University Hospital
Time frame: At time of enrollment of study and after 24 hours
CT data (ABC/2) formula for intracerebral hemorrhage volume
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 Oct 2024.
- Results publication: PubMed 28178408An SJ, Kim TJ, Yoon BW. Epidemiology, Risk Factors, and Clinical Features of Intracerebral Hemorrhage: An Update. J Stroke. 2017 Jan;19(1):3-10. doi: 10.5853/jos.2016.00864. Epub 2017 Jan 31.
Related trials for ICH - Intracerebral Hemorrhage
Not yet recruiting
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Aphasia (BG-Aphasia-01)
Expressive Aphasia, Aphasia Following Cerebral Infarction
RecruitingObservational study
Smartphone Enabled Detection of Cognitive Motor Dissociation in the ICU
Traumatic Brain Injury (TBI) Patients, Intracerebral Hemorrhage
Recruiting
Stereotactic Thrombolysis With Tenecteplase for Supratentorial Intracerebral Hemorrhage
Intracerebral Haemorrhage, Minimally Invasive Treatment
RecruitingObservational study
Sleep to Predict Recovery In Unconscious Patients With Acute Brain Injury
Traumatic Brain Injury (TBI) Patients, Intracerebral Hemorrhage (ICH)
Recruiting
PREcision MApping and NEuromodulation After Spontaneous Intracerebral Hemorrhage: The PREMANE Trial
Spontaneous Intracerebral Hemorrhage
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Nageh Fouly, Professor contact
Norhan MH Bakri, MD principal investigator
Assiut University
Ahmed NasrEldein, Ass.Professor study director
Assiut University
Questions about this trial
What is this clinical trial studying?
An observational study of ICH - Intracerebral Hemorrhage, run by Assiut University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 23 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Norhan MH Bakri, MBBS (+201022141426, nourmhb@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Volume of Intracerebral Hemorrhage Among Stroke Patients Admitted to Assiut University Hospital (time frame: At time of enrollment of study and after 24 hours). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06654544, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Oct 2024.